How Can We Help You?
There may be options to help you afford your Genentech medicine, no
matter what type of health insurance you have. Your OCREVUS Patient
Navigator can help you find out which option may be right for
Your OCREVUS Patient Navigator is your personal guide during your treatment with OCREVUS.
Once you enroll in OCREVUS Access Solutions, you will be teamed up with your own Patient Navigator.
This person will work with you and your health care team during your
treatment with OCREVUS.
What does your Patient Navigator do?
|Before your infusion||After your infusion|
| || |
To reach your Patient Navigator at any time during your treatment, call (844) OCREVUS/(844) 627-3887.
To enroll in OCREVUS Access Solutions, you and your doctor must fill
out the OCREVUS
If you need help with your co-pay for your Genentech medicine, your Patient Navigator can refer you to an independent co-pay assistance foundation.
An independent co-pay assistance foundation is a charitable
organization that gives financial assistance for medicines.
Call OCREVUS Access Solutions at (844) OCREVUS (844-627-3887) for a referral.
If you would like to contact a foundation directly, you can use the information below:
No funds are available at this time.
Please call Genentech Access Solutions at (866) 4ACCESS /
(866) 422-2377. We may be able to help.
Independent co-pay assistance foundations have their own rules for
eligibility. We cannot guarantee a foundation will help you. We only
can refer you to a foundation that supports your disease state. This
information is provided as a resource for you. We do not endorse or
show financial preference for any particular foundation. The
foundations in this list are not the only ones that might be able to
The Genentech Access to Care Foundation, or GATCF, can help you receive your Genentech medicine free of charge, if you qualify.
GATCF helps people who are:
- Uninsured—People who do not have insurance
- Rendered uninsured—People whose health insurance does not cover their Genentech medicine
Underinsured—People who have health insurance (including
commercial or government insurance plans), but pay more than a
certain amount for their medicines each year
Other eligibility criteria must be met to qualify for free medicine from GATCF. You might qualify if you meet the requirements below.
Do you have health insurance?
Is your yearly household income less than $100,000?
Is your yearly household income less than $150,000?
Do you spend 5% or more of your yearly household income on the out-of-pocket costs for your Genentech medicine?
You Might Qualify for Free Medicine From GATCF
To apply for GATCF, you and your doctor's office will need to complete the OCREVUS Start Form.
You only need to fill out Section 1 of this form.
Remember to fill out Sections 1A and 1C to apply to GATCF.
Other Options May Be Available
You do not appear to qualify for free medicine from GATCF. However, other patient assistance options may be available to help you.
Your Patient Navigator can walk you through your options. You can also find out which option may be right for you using our Patient Assistance Tool.
Call (844) OCREVUS/(844) 627-3887 to talk to your Patient Navigator.
You’ll have to fill out Sections 1A and 1C of the OCREVUS Start Form to apply for GATCF.
If you have health insurance, you must have already tried other types of patient assistance to qualify for free Genentech medicine from GATCF. This includes the OCREVUS Co-pay Program and support from independent co-pay assistance foundations. You must also meet financial criteria. If you do not have insurance, you must meet different financial criteria.
Your Patient Navigator can help you enroll in the OCREVUS Co-pay Program. It can help you with the out-of-pocket costs of your Genentech medicine, if you’re eligible.
The OCREVUS Co-pay Program helps patients with commercial health
insurance. This might be a plan you get through your employer or one
you purchased through a Health Insurance Marketplace like
HealthCare.gov. To qualify, you must also meet other criteria.
In order to be eligible for the OCREVUS Co-pay Program, the patient
must have commercial insurance, must not have Medicare, Medicaid or
other government insurance, and must meet other eligibility
criteria. They also must agree to the rules set forth in the terms
and conditions for the program. Please visit OCREVUS.com/Copay for the full list of terms and conditions.
How Your Patient Navigator Can Help You
Your Patient Navigator works with you, your doctor’s office, your health insurance plan, your infusion site and your specialty pharmacy. We might contact you for more information.
Important Safety Information & Indication
What it Treats
What is OCREVUS?
OCREVUS is a prescription medicine used to treat adults with relapsing or primary progressive forms of multiple sclerosis.
It is not known if OCREVUS is safe or effective in children.
Who should not receive OCREVUS?
Do not receive OCREVUS if you have an active hepatitis B virus (HBV) infection.
Do not receive OCREVUS if you have had a life threatening allergic reaction to OCREVUS. Tell your healthcare provider if you have had an allergic reaction to OCREVUS or any of its ingredients in the past.
Important Safety Information
What is the most important information I should know about OCREVUS?
OCREVUS can cause serious side effects, including:
- Infusion reactions: OCREVUS can cause infusion reactions that can be serious and require you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you get any of these symptoms:
- itchy skin
- coughing or wheezing
- trouble breathing
- throat irritation or pain
- feeling faint
- redness on your face (flushing)
- swelling of the throat
- shortness of breath
- fast heart beat
If you get infusion reactions, your healthcare provider may need to stop or slow down the rate of your infusion.
- OCREVUS increases your risk of getting upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes infections. Tell your healthcare provider if you have an infection or have any of the following signs of infection including fever, chills, a cough that does not go away, or signs of herpes (such as cold sores, shingles, or genital sores). These signs can happen during treatment or after you have received your last dose of OCREVUS. If you have an active infection, your healthcare provider should delay your treatment with OCREVUS until your infection is gone.
- Progressive Multifocal Leukoencephalopathy (PML): Although no cases have been seen with OCREVUS treatment, PML may happen with OCREVUS. PML is a rare brain infection that usually leads to death or severe disability. Tell your healthcare provider right away if you have any new or worsening neurologic signs or symptoms. These may include problems with thinking, balance, eyesight, weakness on 1 side of your body, strength, or using your arms or legs.
- Hepatitis B virus (HBV) reactivation: Before starting treatment with OCREVUS, your healthcare provider will do blood tests to check for hepatitis B viral infection. If you have ever had hepatitis B virus infection, the hepatitis B virus may become active again during or after treatment with OCREVUS. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure or death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop receiving OCREVUS.
- Weakened immune system: OCREVUS taken before or after other medicines that weaken the immune system could increase your risk of getting infections.
Before receiving OCREVUS, tell your healthcare provider about all of your medical conditions, including if you:
- have ever taken, take, or plan to take medicines that affect your immune system, or other treatments for MS.
- have ever had hepatitis B or are a carrier of the hepatitis B virus.
- have had a recent vaccination or are scheduled to receive any vaccinations. You should receive any required vaccines at least 6 weeks before you start treatment with OCREVUS. You should not receive certain vaccines (called ‘live’ or ‘live attenuated’ vaccines) while you are being treated with OCREVUS and until your healthcare provider tells you that your immune system is no longer weakened.
- are pregnant, think that you might be pregnant, or plan to become pregnant. It is not known if OCREVUS will harm your unborn baby. You should use birth control (contraception) during treatment with OCREVUS and for 6 months after your last infusion of OCREVUS.
- are breastfeeding or plan to breastfeed. It is not known if OCREVUS passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take OCREVUS.
What are the possible side effects of OCREVUS?
OCREVUS may cause serious side effects, including:
- Risk of cancers (malignancies) including breast cancer. Follow your healthcare provider’s instructions about standard screening guidelines for breast cancer.
Most common side effects include infusion reactions and infections.
These are not all the possible side effects of OCREVUS.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
For more information, go to www.OCREVUS.com or call 1-844-627-3887